2025年7月22日

XRP Healthcare’s Strategic Leap: Inside Our Public Listing Deal with AAJ and ARC Group

We’re thrilled to announce a major milestone: XRP Healthcare M&A Holding Inc. has officially signed a Definitive Agreement with AAJ Capital 3 Corp. , and the esteemed ARC Group is serving as our exclusive financial

本文目前提供英文版本。

XRP Healthcare’s Strategic Leap: Inside Our Public Listing Deal with AAJ and ARC Group

We’re thrilled to announce a major milestone: XRP Healthcare M&A Holding Inc. has officially signed a Definitive Agreement with AAJ Capital 3 Corp., and the esteemed ARC Group is serving as our exclusive financial advisor.

If you’re unfamiliar with capital markets, terms like RTO, CPC, TSXV, and Definitive Agreement might sound confusing. But don’t worry - we’ll break everything down in clear, jargon-free language so you understand what it means and why it matters.

Taking a Smarter Path to the Public Markets

When companies decide to go public, most people picture an IPO (Initial Public Offering) - a popular route where businesses sell shares on a stock exchange for the first time.

But we’re taking a faster, more flexible path: a Reverse Takeover (RTO).

What’s a Reverse Takeover (RTO), and How Does It Work?

Instead of launching an IPO from scratch, we’re merging with AAJ Capital 3 Corp., a Capital Pool Company (CPC) listed on the TSX Venture Exchange (TSXV) under the symbol AAAJ.P.

By following this route, XRP Healthcare M&A Holding Inc. becomes the new public entity. We’ll phase out the current listing (AAAJ.P) and replace it with our new name and ticker symbol on the TSXV.

The TSXV refers to this process as a Qualifying Transaction (QT) - a streamlined pathway designed to help high-growth companies like ours access the public markets more efficiently than with a traditional IPO.

What Does the “Definitive Agreement” Mean?

This agreement isn’t just a handshake - it’s a legally binding contract that defines every aspect of the merger, from share exchanges to legal obligations for closing the deal.

In short: both parties have agreed to move forward, pending regulatory approval.

Why ARC Group’s Involvement Matters

ARC Group brings elite financial expertise and a strong track record in international M&A and listings. They’re guiding us through jurisdictions including Canada, the UAE, and East Africa, ensuring we complete this transaction to the highest global standards. Their presence boosts both our credibility and strategic direction.

Why This Move Matters for XRP Healthcare

This isn’t just a financial step - it’s a strategic leap forward in our mission to transform healthcare access across Africa and other emerging markets.

We’ve already started acquiring pharmacies in Uganda, and our AI-powered, multilingual XRPH app is live - connecting users with healthcare insights, prescription support, and localized tools.

Going public empowers us to:

  • Gain greater visibility and trust

  • Attract institutional funding

  • Scale our AI and M&A model across regions

This means faster rollouts, broader reach, and deeper integration with the communities we serve.

What Comes Next?

With the Definitive Agreement signed, here’s what to expect:

  • Regulatory submission of the deal to the TSXV

  • Final approvals and compliance checks

  • Trading begins under the new XRP Healthcare M&A Holding Inc. name

  • Continued expansion of our AI platform and pharmacy acquisition roadmap

More Than a Business Move It’s a Movement

This journey isn’t just about listing shares. It’s about proving that a company with roots in London, operations in Dubai, and a vision for Africa.  Can meet the highest standards of international capital markets.

It’s about connecting innovation to impact, and capital to communities.

We’re honored to partner with ARC Group and AAJ Capital 3 Corp. in this endeavor and even more energized by what it means for the future of health access across the globe.

The path to public trading is now paved and this is just the beginning.


零售网络接入

零售网络接入通过与 United Networks of America(UNA)的协议实现。展示药房品牌标识并不表示 XRP Healthcare M&A Holding Inc. 拥有、背书或与其存在直接合作关系。

战略健康技术合作

技术合作反映协作或基于项目的合作关系。除非明确说明,展示并不表示股权所有或背书。

制药与供应合作

制药和供应关系反映已收购运营实体内现有的商业安排。展示并不表示超出标准商业供应协议之外的排他性或背书。

顾问

顾问为 XRP Healthcare M&A Holding Inc. 提供专业服务。除非公开披露,否则不表示合作伙伴关系或所有权权益。

所有第三方商标均为其各自所有者的财产。除非明确说明,展示并不表示背书、所有权或合作关系。

XRP Healthcare’s Strategic Leap: Inside Our Public Listing Deal with AAJ and ARC Group